Literature DB >> 22332692

Medicare Part D enrollees' use of out-of-plan discounted generic drugs.

Bruce Stuart, F Ellen Loh, Ellen F Loh.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22332692     DOI： 10.1111/j.1532-5415.2011.03812.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  9 in total

1.  Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry.

Authors:  Prateeti Khazanie; Li Liang; Lesley H Curtis; Javed Butler; Zubin J Eapen; Paul A Heidenreich; Deepak L Bhatt; Eric D Peterson; Clyde W Yancy; Gregg C Fonarow; Adrian F Hernandez
Journal:  Circ Heart Fail       Date:  2016-02       Impact factor: 8.790

2.  Medication Adherence Based on Part D Claims for Patients With Heart Failure After Hospitalization (from the Atherosclerosis Risk in Communities Study).

Authors:  Carla A Sueta; Jo E Rodgers; Patricia P Chang; Lei Zhou; Emily M Thudium; Anna M Kucharska-Newton; Sally C Stearns
Journal:  Am J Cardiol       Date:  2015-05-08       Impact factor: 2.778

3.  Assessing Medicare Part D claim completeness using medication self-reports: the role of veteran status and Generic Drug Discount Programs.

Authors:  Lei Zhou; Sally C Stearns; Emily M Thudium; Khalid A Alburikan; Jo E Rodgers
Journal:  Med Care       Date:  2015-05       Impact factor: 2.983

4.  A Comparison of Self-reported Medication Adherence to Concordance Between Part D Claims and Medication Possession.

Authors:  Samuel T Savitz; Sally C Stearns; Lei Zhou; Emily Thudium; Khalid A Alburikan; Richard Tran; Jo E Rodgers
Journal:  Med Care       Date:  2017-05       Impact factor: 2.983

5.  Gaps in Adherence to Guideline-Directed Medical Therapy Before Defibrillator Implantation.

Authors:  Gregg C Fonarow; Boback Ziaeian
Journal:  J Am Coll Cardiol       Date:  2016-03-08       Impact factor: 24.094

6.  Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.

Authors:  Gang Fang; Izabela E Annis; Joel F Farley; Nirosha Mahendraratnam; Ryan P Hickson; Til Stürmer; Jennifer G Robinson
Journal:  Pharmacotherapy       Date:  2017-12-11       Impact factor: 4.705

7.  Who enrolls in the Medicare Part D prescription drug benefit program? Medication use among patients with heart failure.

Authors:  Zubin J Eapen; Bradley G Hammill; Soko Setoguchi; Kevin A Schulman; Eric D Peterson; Adrian F Hernandez; Lesley H Curtis
Journal:  J Am Heart Assoc       Date:  2013-09-11       Impact factor: 5.501

8.  It's Not Too Late to Improve Statin Adherence: Association Between Changes in Statin Adherence from Before to After Acute Myocardial Infarction and All-Cause Mortality.

Authors:  Ryan P Hickson; Jennifer G Robinson; Izabela E Annis; Ley A Killeya-Jones; Gang Fang
Journal:  J Am Heart Assoc       Date:  2019-04-02       Impact factor: 5.501

9.  Changes in Statin Adherence Following an Acute Myocardial Infarction Among Older Adults: Patient Predictors and the Association With Follow-Up With Primary Care Providers and/or Cardiologists.

Authors:  Ryan P Hickson; Jennifer G Robinson; Izabela E Annis; Ley A Killeya-Jones; Maarit Jaana Korhonen; Ashley L Cole; Gang Fang
Journal:  J Am Heart Assoc       Date:  2017-10-19       Impact factor: 5.501
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.